Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
  1. 4 Planned sale Director sold 1,560 shares at $3.05 ($4,758)
  2. 4 Open-market sale Director sold 292 shares at $3.05 ($891)
  3. 4 Planned sale Chief Information Officer sold 2,000 shares at $2.93 ($5,860)
  4. 4 Open-market sale Chief Data Officer sold 32,203 shares at $2.94 ($94,677)
  5. 4 Planned sale Chief Data Officer sold 1,986 shares at $3.51 ($6,971)
  6. 4 Open-market sale Chief Executive Officer sold 11,594 shares at $2.62 ($30,376)
  7. 4 Open-market sale Chief Data Officer sold 7,073 shares at $2.62 ($18,531)
  8. 4 Open-market sale General Counsel sold 7,059 shares at $2.62 ($18,495)
  9. 4 Open-market sale Chief Information Officer sold 6,528 shares at $2.62 ($17,103)
  10. 4 Open-market sale Chief Scientific Officer sold 7,767 shares at $2.62 ($20,350)
  11. 4 Open-market sale Chief Financial Officer sold 6,351 shares at $2.62 ($16,640)
  12. 4 Open-market sale Director sold 221 shares at $3.04 ($672)
  13. 4 Planned sale Chief Information Officer sold 2,000 shares at $3.07 ($6,140)
  14. 4 Grant or award Chief Medical Officer acquired 75,000 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Planned sale Chief Information Officer sold 2,000 shares at $3.18 ($6,360)
  17. 4 Open-market sale Director sold 227 shares at $3.16 ($717)
  18. 4 Open-market sale Chief Executive Officer sold 3,246 shares at $3.13 ($10,160)
  19. 4 Open-market sale Chief Data Officer sold 1,271 shares at $3.13 ($3,978)
  20. 4 Open-market sale General Counsel sold 934 shares at $3.13 ($2,923)

Page 4 of 16 · 313 filings